A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
Clinical trial NCT06005740 · RECRUITING
Trial details
- NCT number
- NCT06005740
- Sponsor
- TORL Biotherapeutics, LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-04
- Primary completion
- 2025-10-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.